Brussels, Belgium

Anne M Boland

This inventor holds 2 USPTO granted patents. Top assignees: Ludwig Institute for Cancer Research Limited, Universitè Catholique De Louvain. Active years: 1999-2003.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1999-2003

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Anne M Boland: Innovator in Protein Delivery Systems

Introduction

Anne M Boland is a prominent inventor based in Brussels, Belgium. She has made significant contributions to the field of biotechnology, particularly in the delivery of proteins into eukaryotic cells. With a total of 2 patents, her work has the potential to impact various therapeutic applications.

Latest Patents

Anne's latest patents include innovative methods for the delivery of proteins into eukaryotic cells using recombinant Yersinia. The first patent details the use of recombinant Yersinia for this purpose, including related compositions and methods of treatment. The second patent reiterates this groundbreaking approach, emphasizing the importance of these methods in advancing medical treatments and related assays.

Career Highlights

Throughout her career, Anne has worked with esteemed organizations such as the Ludwig Institute for Cancer Research Limited and Université Catholique de Louvain. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to significant advancements in biotechnology.

Collaborations

Some of her notable coworkers include Pierre B Van Der Bruggen and Guy R Cornelis. Their collaborative efforts have further enhanced the research and development of innovative solutions in protein delivery systems.

Conclusion

Anne M Boland's contributions to the field of biotechnology, particularly in protein delivery systems, showcase her innovative spirit and dedication to advancing medical science. Her patents and collaborations reflect her commitment to improving therapeutic methods and enhancing patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…